Cue Biopharma (CUE) Treasury Shares (2019 - 2022)

Cue Biopharma has disclosed Treasury Shares across 4 years of filings, most recently posting $6667.0 for Q2 2022.

• Treasury Shares for Q2 2022 came in at $6667.0, down 96.87% year-over-year; the trailing twelve-month figure through Jun 2022 was $6667.0 (down 96.87% YoY), and the FY2021 annual result was $98335.0, down 57.25% from the prior year.
• Treasury Shares came in at $6667.0 for Q2 2022 at Cue Biopharma, roughly flat from $6667.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $263335.0 in Q3 2020 to a low of $6667.0 in Q1 2022.
• The 4-year median for Treasury Shares is $172502.5 (2021), against an average of $151334.8.
• Across the five-year window, Treasury Shares soared 130.0% in 2020 and slumped 96.87% in 2022, its largest moves.
• Cue Biopharma's Treasury Shares stood at $100000.0 in 2019, then jumped by 130.0% to $230002.0 in 2020, then sank by 57.25% to $98335.0 in 2021, then sank by 93.22% to $6667.0 in 2022.
• The last three Treasury Shares figures came in at $6667.0 (Q2 2022), $6667.0 (Q1 2022), and $98335.0 (Q4 2021), per Business Quant data.